FDA Eases Restrictions on Glaxo Diabetes Drug Avandia

U.S. Food and Drug Administration said Monday that it is removing some restrictions on the prescription of GlaxoSmithKline Plc's Avandia- a diabetes drug. The agency eased rules on the drug's use after studies showed that it doesn't increase heart attack risk.